Lexicon Pharmaceuticals, Inc. announced that Lonnel Coats has provided notice of his retirement as member of its board of directors, effective July 7, 2024, his 10th anniversary with the company. The board of directors has initiated a search for a new chief executive officer which will consider both internal and external candidates.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.855 USD | -4.38% | -1.85% | +21.24% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.24% | 701M | |
+7.77% | 113B | |
+10.39% | 106B | |
+0.41% | 22.27B | |
-11.88% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.08% | 17.24B | |
+6.52% | 14.29B | |
+36.23% | 12.52B |
- Stock Market
- Equities
- LXRX Stock
- News Lexicon Pharmaceuticals, Inc.
- Lexicon Pharmaceuticals, Inc. Announces Resignation of Lonnel Coats as Member of Its Board of Directors, Effective July 7, 2024